1 min left
Brand-name GLP-1
PlushCare Weight Loss review: cost, effectiveness, and 2026 verdict
PlushCare's weight loss program offers GLP-1 prescriptions through its primary care telehealth platform.
0.0
/ 10
Diabetologist, Certified Diabetes Educator1 min read
Starting price
$99/mo
cash pay
FDA status
FDA-approved
Brand drug
Format
Weekly injection
Self-administered
Refund policy
Pharmacy-dependent
Rx drug — no refund
Check PlushCare Weight Loss coverage
Coverage by insurer
Tap your plan for prior authorization criteria, copay range, and step therapy rules.
Compare PlushCare Weight Loss with
One-tap side-by-side. Score + price + side-effect profile.
How PlushCare Weight Loss works through telehealth
Three steps from intake to delivery
- 01
Online consult
Answer a 5-minute health intake. A licensed clinician reviews your history, BMI, comorbidities, and prior medications.
- 02
Prescription decision
If clinically appropriate, your clinician writes a prescription. Insurance PA submitted on your behalf, or cash-pay routed to manufacturer direct channels.
- 03
Delivery and follow-up
Medication ships from a verified pharmacy. Monthly check-ins for titration, side-effect management, and dose adjustments.
PlushCare Weight Loss score breakdown
What you'll pay for PlushCare Weight Loss
Pick your insurance situation. Your monthly cost + best route update live.
Estimates only. Final out-of-pocket varies by plan tier, formulary, deductible status, and pharmacy.
What PlushCare Weight Loss looks like
Placeholder visuals. Real product imagery shipping pending DEA-compliant photo licensing.
Coverage in progress
We require a 12-section template before publishing. This page covers 1 of 12.
1/12
8%
- Bottom line
- How it works
- Who it's for
- Efficacy
- Side effects
- Dosing
- Cost
- Insurance
- Refund
- Switching
- Discontinuation
- FAQ
P
As diabetologist, certified diabetes educator, I check every claim on this review against FDA labeling, peer-reviewed trial data, and current clinical guidelines. If something's off, we publish a correction.
Priya Patel, MD, CDE
Verified medical reviewerDiabetologist, Certified Diabetes Educator
Editorial score breakdown
Six axes, one sentence each. No black-box rating — how we score.
- Effectiveness7.5/10
- Safety8.0/10
- Value7.0/10
- Accessibility7.5/10
- User experience7.5/10
- Trust7.5/10
Plan length calculator
Most providers discount longer commitments. Estimate effective monthly cost across plan lengths.
Effective monthly
$99
Total at signup
$99
Savings vs monthly
$0
Discount assumptions are based on common industry tiers (5% at 3 mo, 10% at 6 mo, 17% at 12 mo). Actual provider discounts vary — confirm at checkout.
Pros and cons
Pros
- ✓ Includes primary care visits
- ✓ Insurance accepted
Cons
- ✗ Less specialized than dedicated weight loss platforms
In-depth review
1/12 sectionsCost — what you'll actually pay
From $99/monthly
Independently reviewed
Continue with PlushCare Weight Loss?
See current pricing and program details directly from the provider.
Independently reviewed
Ready to start with PlushCare Weight Loss?
Editorial review independent of affiliate status. Affiliate disclosure on every page.
Regulatory transparency
FDA / regulatory actions we are tracking
- September 2025·FDA
Warning letters to telehealth GLP-1 advertisers
FDA issued warning letters to Hims & Hers and several compounding pharmacies over weight-loss advertising claims and compounded semaglutide / tirzepatide marketing post-shortage resolution. Editorial: providers featured here have been reviewed for compliance with current FDA rules.
Read the source ↗ - May 2026·FDA
Semaglutide and tirzepatide shortages declared resolved
FDA confirmed both molecules off the official shortage list. 503A and 503B compounding pharmacies can no longer compound semaglutide or tirzepatide except for documented individual medical-necessity cases. Patients on compounded GLP-1s should plan to transition to brand or off-label scripts.
Read the source ↗
We track regulatory actions and surface them publicly, even when they involve advertised partners. Editorial rankings reflect verification, not commission.
Editorial corrections
Updates to PlushCare Weight Loss review
Dated record of factual corrections and material updates to this page. We publish corrections rather than silently edit. Trust signal, not legal compliance.
- 2026-05-26· All review pages
Added editorial blocks: weight-loss projection slider, savings card workflow, side-effect onset chart, FDA regulatory transparency, numbered citations, plateau diagnostic cross-link. Refreshed AI product photography to 1536x1024 editorial-grade renders.
- 2026-05-15· All review pages
Added inline Jargon tooltip system across editorial body. Glossary appendix shows medical terms used per drug.
- 2026-04-12· All review pages
FAQ schema (FAQPage JSON-LD) added per review. People-also-ask block cross-links to Q&A library.
Medical glossary
Terms used in this PlushCare Weight Loss review
Quick reference for medical and regulatory terms above. Each term links to a longer explainer if you want deeper context.
- GLP-1
- Glucagon-like peptide-1 receptor agonist — class of drugs that mimic a gut hormone to reduce appetite and slow stomach emptying.
- BMI
- Body mass index = weight (kg) / height (m)². Overweight: 25-29.9. Obese: ≥30. FDA threshold for Wegovy/Zepbound: BMI ≥30, or ≥27 with weight-related condition.
- Titration
- Gradual dose increase over weeks to build tolerance and minimize GI side effects. Typical GLP-1 schedule: 4-week steps up to the maintenance dose.
- Prior authorization
- Insurance step that requires your doctor to document medical necessity before the plan will cover the drug. Adds 3-14 days but is often required for GLP-1s.
- MTC
- Rare thyroid cancer; GLP-1s carry an FDA black-box warning for personal or family history of MTC or MEN 2.
About this review
Was this useful?
Compare these alternatives
Other products in the same category, ranked by our editorial score.
Related reading